Lower glucose target linked to improved mortality in critically ill

“Given improvements in insulin delivery and glucose monitoring, a reassessment of potential benefits of [intensive insulin therapy] should once again be evaluated in a prospective randomized trial,” they wrote.

Dr. Hersh and his coauthors declared no financial or nonfinancial disclosures related to the study.

SOURCE: Hersh AM et al. CHEST 2018. doi: 10.1016/j.chest.2018.04.025.